Press release
Custics Singapore's HAUTUKI Secures FDA OTC Product Registration and Excels in Skin Sensitivity Testing
HAUTUKI, a cutting-edge product developed through technology transferred from Seoul National University, integrates a unique blend of vitamins and nutrients designed to amplify its effectiveness. At the core of HAUTUKI's innovation is a patented peptide ligand from the Department of Biotechnology at Seoul National University. This advanced technology is engineered to enhance the delivery of large molecules through the skin, thereby optimizing their absorption and therapeutic impact.
Image: https://www.abnewswire.com/uploads/02937bb6b2765636dcd7e5327178d886.png
A representative from HAUTUKI commented, "Securing FDA OTC registration is a testament to HAUTUKI's quality and safety. Furthermore, HAUTUKI has successfully passed rigorous skin sensitivity testing with a score of 0, indicating zero irritation. This result underscores our commitment to providing a product that is not only effective but also gentle on the skin."
Image: https://www.abnewswire.com/uploads/8399db0228de20bec113cc77633a2d73.png
The representative further stated, "Our goal is to ensure that consumers can purchase HAUTUKI with complete confidence. We are dedicated to maintaining the highest standards of safety and efficacy for our users."
Image: https://www.abnewswire.com/uploads/df7354c718aac22bea80e6d8581aa693.png
For more information, visit HAUTUKI's official website [https://hautuki.sg/].
Distributor Name - Amit Biswas
Distribution Agency Name - Grow With Amit
Distributor Contact Number - 1169312053
Media Contact
Company Name: Grow With Amit
Contact Person: Amit Biswas
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=custics-singapores-hautuki-secures-fda-otc-product-registration-and-excels-in-skin-sensitivity-testing]
Country: India
Website: https://www.fiverr.com/grow_withamit
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Custics Singapore's HAUTUKI Secures FDA OTC Product Registration and Excels in Skin Sensitivity Testing here
News-ID: 3638338 • Views: …
More Releases from ABNewswire
Multiple Sclerosis Market Insights Highlight Expanding Outlook Till 2034, DelveI …
The Key Multiple Sclerosis Companies in the market include - Biogen, Immune Response BioPharma, ImCyse, Atara Biotherapeutics, Emerald Health Pharmaceuticals, Sanofi, RemeGen, Gossamer Bio, 4D Pharma, HuniLife Biotechnology, Anokion, GSK plc, GeNeuro, Immunic Therapeutics, Sanofi, Hoffman-La-Roche, and others.
DelveInsight's "Multiple Sclerosis Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Multiple Sclerosis, historical and forecasted epidemiology as well as the Multiple Sclerosis market trends in the United…
Climb Greater Heights by Tony Jeton Selimi Becomes a #1 Amazon Bestseller, Empow …
Tony Jeton Selimi's #1 international bestseller, Climb Greater Heights is an empowering and transformational blueprint for entrepreneurs, leaders, and visionaries determined to elevate their business, leadership, and legacy to unprecedented heights.
Image: https://www.abnewswire.com/upload/2025/10/7cf2246073c1622d44d855de3f71ffde.jpg
Visionary author, speaker, and transformational coach Tony Jeton Selimi has achieved #1 international bestseller status with his groundbreaking new release, Climb Greater Heights: How to Accelerate Your Business Growth, Amplify Your Success, and Build a Legacy of Significance. The…
Conductive Hearing Loss Market to Evolve Rapidly Over the Next Decade by 2034, D …
The Key Conductive Hearing Loss Companies in the market include - MED-EL Cochlear Implant System, and others.
DelveInsight's "Conductive Hearing Loss Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Conductive Hearing Loss, historical and forecasted epidemiology as well as the Conductive Hearing Loss market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Conductive Hearing…
Paroxysmal Nocturnal Hemoglobinuria Pipeline 2025: Comprehensive Clinical Trials …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Paroxysmal Nocturnal Hemoglobinuria pipeline constitutes 20+ key companies continuously working towards developing 25+ Paroxysmal Nocturnal Hemoglobinuria treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Paroxysmal Nocturnal Hemoglobinuria Pipeline Insight, 2025 [https://www.delveinsight.com/sample-request/paroxysmal-nocturnal-hemoglobinuria-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Paroxysmal Nocturnal Hemoglobinuria Market.
The…
More Releases for HAUTUKI
Hautuki Patch Demonstrates Growth Potential and Safety in Clinical Study
Hautuki Clinically Proven to Support Height Growth and Ensure Safety
Custics announced that its height-supporting nutrient patch, Hautuki, has been proven effective and safe through a clinical study conducted at Bestian Hospital over the course of approximately one year.
Image: https://www.abnewswire.com/upload/2025/05/75daaface7cea909f35fd494150fea0f.PNG
The study was conducted over 11 months, from January to November 2024, and involved 40 children between the ages of 5 and 12.
After eight weeks, the group that used the Hautuki patch…
CUSTICS SINGAPORE's Growth Nutrient Patch 'Hautuki' Completes Clinical Study
Image: https://www.abnewswire.com/upload/2025/01/d0c11fb6ef950d96ffc92b987934691b.jpg
CUSTICS SINGAPORE PTE. LTD. (hereafter referred to as "CUSTICS SINGAPORE [https://hautuki.sg/]") has successfully completed clinical study on its 'Hautuki [https://hautuki.sg/]' growth nutrient patch in collaboration with Bestian Hospital, demonstrating its effectiveness in promoting height growth and confirming its safety. The study was conducted in adherence to Good Clinical Practice (GCP) standards and the approval of the Institutional Review Board (IRB), ensuring its reliability.
From January to November 2024, the study…
Hautuki, A Globally Recognized Innovative Patch Type Nutrition Solution for Chil …
Hautuki, an innovative children's nutrition product manufactured in South Korea, is gaining global recognition. Exported to countries including the United States, Singapore, Hong Kong, Taiwan, Malaysia, Indonesia, China, and the Philippines, Hautuki has established itself as a trusted brand in international markets.
CUSTICS, the company behind Hautuki, operates legal entities in South Korea, Singapore, Taiwan, and Hong Kong, strengthening its global presence. Based on its vision to "shine and illuminate," CUSTICS…
HAUTUKI Innovates Efficient Vitamin D Delivery for Children through Transdermal …
Recent nutritional surveys conducted both domestically and internationally indicate that more than 80% of children in their growth phase suffer from vitamin D deficiency or insufficiency. Research also shows that children with stunted growth are more prone to vitamin D deficiency compared to their peers. In countries with frequent rainy or overcast days, ensuring adequate vitamin D intake is naturally more challenging.
Image: https://www.abnewswire.com/uploads/d2d7d3db97fca5f29490d3971d5e13d5.jpg
CUSTICS Inc. (CEO LEE KANG IL), in their…
CUSTICS Launches Hautuki as an OTC Product in Singapore
CUSTICS SINGAPORE PTE. LTD. has announced that its product, Hautuki, has already completed registration with the U.S. FDA Administration OTC Product.
According to a company representative, Hautuki was developed by CUSTICS Co., Ltd. using TDDS technology previously acquired from Seoul National University. This innovative patch integrates vitamins and various nutrients and is specifically designed to support children's growth.
Image: https://www.abnewswire.com/uploads/85ea01f2e25cff2bd5d8e29463a3d6d2.png
The technology is the "Pore-Permeable Transdermal Peptide Ligand," a patented innovation from the…
Hautuki Introduces Safe and Easy Supplements: Skin-Friendly, Hassle-Free Patch S …
Image: https://www.abnewswire.com/uploads/362587e5d32397d9e2bf61339b424669.png
Singapore - 9 Aug, 2024 - Custics announced the release of "Hautuki," a height growth supplement using patented peptide technology developed by the Department of Biotechnology at Seoul National University.
A Custics official stated that the peptide technology promotes the intracellular delivery of nutrients, enhancing absorption without the need for oral administration. "Hautuki" is registered with the U.S. FDA OTC and has passed skin irritation tests with zero score.
The supplement…
